Fact CheckerSign in

NCT07576647Recruiting

Optimized Recruitment to Drive Equitable Research in Stroke, Empowering Decision-making (ORDERed)

Source: ClinicalTrials.gov · Last updated 9 Oct 2026

Brief summary (registry, in English)

Stroke is a major health issue, especially for women, who are more likely than men to have worse outcomes and lower quality of life after a stroke. Yet, women are under-represented in stroke research, which limits how well treatments work for them. This study aims to change that by testing a new way to recruit women into stroke research using the ORDER toolkit, a set of easy-to-understand, women-focused materials like brochures and videos co-designed with patients. This new approach will be compared to the usual way of recruiting patients. The study will track how many people join, how long it takes to make a decision, and what influences participation. Patients and research coordinators will also share their feedback on the process. Our goal is to make stroke studies more inclusive so that research findings benefit everyone equally.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
1600 (estimated)
First submitted
21 Apr 2026
Start date
17 Aug 2026
Primary completion date
31 Aug 2029
Lead sponsor
McMaster University
Diseases
Stroke
NCT number
NCT07576647

What you commit to

  • Study type: Interventional
  • Planned participants: 1600
  • From 17 Aug 2026 to the primary completion date, 31 Aug 2029
  • 3 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Stroke that started more than 14 days prior to admission

Other illness

  • Cerebral venous thrombosis
  • Subarachnoid hemorrhage
  • Subdural hemorrhage
  • Intracranial hemorrhage due to trauma or underlying mass
  • Imaging abnormality (e.g., dissection, carotid stenosis, vessel irregularity) without imaging or clinical evidence of stroke
  • Stroke that occurred while being admitted for another reason
  • Stroke initially treated outside of Canada
  • Stroke where inpatient stroke or neurology service was not consulted

Other

  • There are no exclusion criteria
    • Participants eligible for StrokeGoRed hospitalized cohort are eligible for ORDERed:
  • Clinical transient ischemic attack without evidence of infarct on neuroimaging

Who the study is looking for

  • All patients, regardless of age or baseline disability, seen in urgent TIA/stroke clinics and referred from the emergency department for suspected TIA or minor stroke will be included over one calendar year
  • Ischemic stroke
  • Intracerebral hemorrhage

Criteria the registry did not label

  • Participants eligible for StrokeGoRed hospitalized cohort are eligible for ORDERed:

Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (3)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Foothills Medical Centre
Coordinator of this site? Confirm its status
CalgaryCanadaNot yet recruiting
Sunnybrook Health Sciences Centre
Coordinator of this site? Confirm its status
TorontoCanadaRecruiting
Vancouver General Hospital
Coordinator of this site? Confirm its status
VancouverCanadaNot yet recruiting

This page is information, not medical advice. Discuss any trial with your doctor.